Stryker Corporation ($SYK) Stock Forecast: Down 1.7% Today

What is Stryker Corporation?

Stryker Corporation (SYK) is a leading medical technology company known for its innovative products and strategic acquisitions in the healthcare industry. The company has been actively involved in mergers and acquisitions to drive growth and expand its global footprint.

Why is Stryker Corporation going down?

SYK stock is down 1.7% on Dec 8, 2025 16:15

• The bearish movement in SYK's stock today could be attributed to the significant insider selling observed recently, with insiders offloading a substantial number of shares worth millions of dollars. This selling pressure might have raised concerns among investors about the company's future performance.
• Despite the insider selling, institutional investors like Natixis have shown confidence in Stryker by increasing their stake, indicating a positive outlook for the company.
• The recent promotion of a new president and COO to lead the M&A strategy could signal potential changes in the company's direction, which might have caused uncertainty among investors and contributed to the bearish market movement.
• While Stryker has been making strategic acquisitions and reporting strong financial results, the mixed signals from insider selling and institutional buying could have created a sense of ambiguity in the market, leading to the bearish trend in SYK's stock today.

SYK Price Chart

SYK Technical Analysis

SYK News

Stryker promotes president, COO to help lead its M&A strategy

Stryker has promoted Spencer Stiles to president and chief operating officer, aiming to strengthen its M&A strategy and sustain high growth. Stiles, a 27-year veteran at the company, will oversee global business strategy and M&A, replacing the previous COO who retired in 2023. This move follows Stryker's recent acquisition spree, including the $4.9 billion purchase of Inari Medical and other deals in 2024, alongside strategic divestitures.

https://www.fiercebiotech.com/medtech/stryker-promotes-stiles-president-coo-lead-its-ma-growth-strategy

ISRG Stock Forms Golden Crossover: Will the Uptrend Continue?

Intuitive Surgical (ISRG) recently formed a golden crossover, signaling long-term bullish momentum driven by robust Q3 performance, accelerating adoption of its da Vinci 5 platform, and strong multi-platform utilization. Despite potential headwinds like margin pressures, China-related challenges, and GLP-1 drug impact on bariatric procedures, analyst estimates for ISRG's EPS have seen upward revisions. The company's expanding global footprint and innovative digital ecosystem suggest a sustained upward trajectory, making it a compelling option for long-term investors.

https://finviz.com/news/248247/isrg-stock-forms-golden-crossover-will-the-uptrend-continue

Winslow Capital Management LLC Sells 11,858 Shares of Stryker Corporation $SYK

Winslow Capital Management LLC reduced its stake in Stryker Corporation by 1.2% in the second quarter, selling 11,858 shares and now owning 964,432 shares valued at approximately $381.6 million. This reduction follows significant insider selling, with company insiders offloading 522,118 shares worth roughly $185.4 million in the last 90 days. Despite the institutional selling, Stryker recently surpassed quarterly earnings estimates, reported strong revenue growth, and holds a "Moderate Buy" analyst rating with an average target price of $433.78.

https://www.marketbeat.com/instant-alerts/filing-winslow-capital-management-llc-sells-11858-shares-of-stryker-corporation-syk-2025-12-08/

SVB Wealth LLC Makes New $4.79 Million Investment in Stryker Corporation $SYK

SVB Wealth LLC has initiated a new investment of $4.79 million in Stryker Corporation (NYSE:SYK) by purchasing 12,095 shares during the second quarter. This new stake comes alongside significant insider selling, with Director Ronda E. Stryker selling shares worth $97.6 million and other insiders selling a total of $185.4 million in the last 90 days. Despite insider sales, analysts maintain a "Moderate Buy" rating for Stryker, with a consensus target price of $433.78, following the company's Q3 earnings beat and positive FY2025 EPS guidance.

https://www.marketbeat.com/instant-alerts/filing-svb-wealth-llc-makes-new-479-million-investment-in-stryker-corporation-syk-2025-12-08/

Natixis Has $35.77 Million Position in Stryker Corporation $SYK

Natixis significantly increased its stake in Stryker Corporation, boosting its holdings by 50.5% to 90,408 shares valued at $35.77 million. This comes as Stryker reported strong quarterly results with better-than-expected EPS and revenue, setting a positive outlook for FY2025. Despite substantial insider selling in the last 90 days, institutional ownership remains high at 77.1%, and analysts maintain a "Moderate Buy" rating for the medical technology company.

https://www.marketbeat.com/instant-alerts/filing-natixis-has-3577-million-position-in-stryker-corporation-syk-2025-12-08/

Trending Today

Ondo ($ONDO) Crypto Forecast: Down 10.1% Today

Stellar ($XLM) Crypto Forecast: Down 5.8% Today

XRP ($XRP) Crypto Forecast: Down 5.9% Today

Solana ($SOL) Crypto Forecast: Down 5.0% Today

Dogecoin ($DOGE) Crypto Forecast: Down 5.1% Today

Sui ($SUI) Crypto Forecast: Down 5.8% Today

Ethereum ($ETH) Crypto Forecast: Down 6.0% Today

Shiba Inu ($SHIB) Crypto Forecast: Down 5.2% Today

Cardano ($ADA) Crypto Forecast: Down 5.0% Today

Ethena ($ENA) Crypto Forecast: Down 9.4% Today

Stryker Corporation Price History

01.07.2025 - SYK Stock was down 5.3%

• Despite surpassing earnings and revenue projections in Q2, Stryker (SYK) witnessed a downturn in its stock performance.
• Concerns regarding increased costs and tariffs potentially impacted margins, influencing market sentiment negatively.
• Comparisons made by investors between Stryker (SYK) and peers like SNN might have contributed to the bearish trend.
• Although Stryker (SYK) has demonstrated strong long-term growth over the last two decades, short-term apprehensions may have outweighed this performance, leading to the recent market decline.

07.02.2025 - SYK Stock was down 5.7%

• Despite recent product launches like Steri-Shield 8 and Sync Badge, SYK stock observed a bearish trend today.
• The market response could be attributed to broader market conditions or profit-taking following a period of considerable outperformance.
• Investor sentiments may be influenced by potential challenges in the healthcare field, such as regulatory modifications or competitive pressures impacting SYK's future growth.
• It is noteworthy that short-term stock fluctuations may not consistently mirror the enduring value and potential of a company like Stryker, known for providing substantial returns to investors across the years.

15.06.2024 - SYK Stock was down 0.9%

• Despite Stryker's strong performance over the years and a diversified product portfolio, the stock experienced a bearish movement recently.
• The preliminary Q2 results of Masimo (MASI) showing strength in the healthcare business might have shifted investor focus away from Stryker.
• The comparison between EYE and SYK as value stocks could have led to some investors favoring the former over the latter, impacting SYK's stock price negatively.
• While Stryker's flagship Mako Total Knee Platform has been driving optimism, market dynamics or external factors may have influenced the recent bearish trend.

02.04.2025 - SYK Stock was up 0.4%

• SYK exceeded Q1 earnings and revenue estimates, showcasing strong financial performance and exceeding market expectations.
• The company's consistent outperformance over the past decade has attracted investor interest, leading to a bullish movement in the stock.
• Expectations of strong segmental performance in Q1 further fueled investor confidence in SYK's growth prospects.
• The comparison with other companies like AHCO and ISRG highlights SYK's position as a valuable stock in the medical technology industry, contributing to its bullish market movement.

10.03.2025 - SYK Stock was down 5.5%

• Possible reasons for the decline in SYK stock today:
• Investors favoring PBH, a competitor in the same sector, over SYK due to perceived differences in value.
• Worries regarding SYK's growth outlook or financial results relative to its industry peers.
• Market instability and general economic conditions affecting overall investor trust in the healthcare products industry.

10.10.2023 - SYK Stock was up 0.0%

• Stryker's stock had a strong bullish movement today, despite a decline in Q3 profits.
• The upgrade from StockNews.com, changing the rating from hold to buy, likely contributed to the positive market movement.
• The news of Stryker's sales surpassing expectations also played a role in boosting investor confidence.
• The increase in holdings by Citizens Financial Group Inc. RI and Sequoia Financial Advisors LLC may have further fueled the bullish sentiment.

23.06.2025 - SYK Stock was up 1.2%

• SYK's strong bullish movement today could be attributed to its consistent outperformance in the market over the past decade, with an impressive average annual return of 14.76%.
• The comparison between Intuitive Surgical and Stryker in the robotic surgery sector might have sparked investor interest in SYK, highlighting its potential as a strong investment opportunity.
• The news of Representative Thomas Kean selling a portion of Stryker stock may have initially caused some uncertainty, but the market quickly rebounded, showcasing confidence in the company's long-term growth prospects.
• Overall, SYK's bullish trend today reflects investor confidence in the company's leadership in orthopedic surgeries and its ability to deliver consistent returns, despite minor fluctuations in stock transactions.

01.01.2024 - SYK Stock was up 6.1%

• Canaccord upgraded Stryker to buy, citing its growth potential, which likely contributed to the bullish movement.
• Stryker's quarterly earnings results exceeded estimates, reflecting strong performance across its segments and geographies.
• The CEO's discussion of offensive M&A goals in 2024 and the company's organic growth may have also fueled investor confidence.
• The surprising 21% stock rally further indicates positive market sentiment towards Stryker Corporation.

15.06.2024 - SYK Stock was down 1.0%

• The bearish movement in SYK's stock today could be attributed to a recent comparison of Boston Scientific and its competitors in the Health Care Equipment & Supplies industry.
• Investors might have reacted to a detailed examination of key financial metrics and growth prospects, potentially leading to a shift in sentiment towards Stryker Corporation.
• The competitive analysis shedding light on Boston Scientific's market standing and growth prospects may have raised concerns among investors about Stryker's position in the industry, prompting the bearish movement in the stock.
• This comparison could have sparked a reevaluation of Stryker's market competitiveness and growth potential, leading to a decline in the stock price as investors adjusted their positions based on the industry comparison.

17.06.2024 - SYK Stock was up 3.5%

• Stryker (SYK) recently finalized the acquisition of Artelon, a strategic move to strengthen its position in the soft tissue fixation market. This acquisition has likely bolstered investor confidence in the company's growth trajectory.
• A comparative analysis of EYE and SYK in terms of value might have also attracted increased attention to Stryker's stock, with investors scouting for robust investment prospects in the healthcare sector.
• In essence, Stryker's positive market performance today can be linked to the encouraging updates regarding the acquisition and its perceived value proposition relative to other market stocks.

08.11.2025 - SYK Stock was down 1.7%

• The bearish movement in SYK's stock today could be attributed to the significant insider selling observed recently, with insiders offloading a substantial number of shares worth millions of dollars. This selling pressure might have raised concerns among investors about the company's future performance.
• Despite the insider selling, institutional investors like Natixis have shown confidence in Stryker by increasing their stake, indicating a positive outlook for the company.
• The recent promotion of a new president and COO to lead the M&A strategy could signal potential changes in the company's direction, which might have caused uncertainty among investors and contributed to the bearish market movement.
• While Stryker has been making strategic acquisitions and reporting strong financial results, the mixed signals from insider selling and institutional buying could have created a sense of ambiguity in the market, leading to the bearish trend in SYK's stock today.

19.07.2025 - SYK Stock was up 1.2%

• Stryker (SYK) has outperformed the market over the past 10 years, showcasing consistent growth and strong performance.
• The comparison between Stryker (SYK) and Smith & Nephew (SNN) might have sparked investor interest, with Stryker being perceived as a more attractive option.
• The positive long-term performance of Stryker (SYK) could have contributed to today's bullish movement, as investors continue to see value in the company's stock.